Tiny od3lslutfnkz8ws52udldillzr0bnnaxjxyxayvmiho

Thomas Chalberg

Founder and Chief Executive Officer, Avalanche Biotechnologies

Dr. Tom Chalberg is a co-founder and CEO of Avalanche Biotechnologies. He has helped the company advance by recruiting the management team and scientific advisory board, and by leading business development efforts related to in-licensing and research collaborations. Prior to joining Avalanche, Dr. Chalberg worked on the ophthalmology team at Genentech, helping to launch Lucentis, a novel therapeutic for age-related macular degeneration. As a Howard Hughes Medical Institute Fellow at Stanford, his research focused on retinal diseases and novel technologies for gene therapy. Dr. Chalberg holds an A.B. from Harvard University, where he graduated magna cum laude and Phi Beta Kappa. He earned a PhD in Genetics from the Stanford University School of Medicine and an MBA from the UC Berkeley Haas School of Business. Tom is a member of the Board of Visionary Scientists for Hope for Vision, a non-profit charity supporting vision research.